pharmstd.com

Pharmstandard is Russia's leading pharmaceutical company committed to developing and manufacturing advanced, high-quality, and affordable medicines that meet healthcare requirements and patients' expectations. Specializing in various pharmacotherapeutic groups, including treatments for cardiovascular diseases, diabetes, growth hormone deficiency, and other conditions, Pharmstandard ensures the production of essential pharmaceutical products and new medications. With state-of-the-art pharmaceutical factories that adhere to GMP and ISO quality standards, Pharmstandard's manufacturing capacity exceeds 1.7 billion packs per year.

The company's strategic development areas include the development of new products, expansion of the product portfolio, and participation in the state import substitution program. Pharmstandard is also dedicated to innovation, efficiency, and social responsibility, ensuring the highest quality standards and the safety and efficacy of its pharmaceuticals. Committed to the environment and future generations, Pharmstandard's operations are based on rigorous internal pharmacovigilance, support for vulnerable social groups, and continual investment in new products and manufacturing technologies.